Accordingly, TILs in teratoma and choriocarcinoma expressed the lowest level of PD-L1, which could be one of mechanisms contributing to teratoma treatment resistance and aggressive biological behavior of choriocarcinoma. This evidence concerns the gene CD274 and teratoma.